Neuroscience seminars
December 2020
In this talk series, addiction neuroscientists from across the world share their personal stories/experiences on the beauty of addiction neuroscience and how/why they have decided to invest their scientific life in this field. We hope that this talk series would encourage and support a new generation of young and passionate addiction neuroscientists in different countries to revolutionize the field of addiction medicine.
Neural and Molecular mechanisms of memory for contextual cues
Sydney Trask· University of Wisconsin, Milwaukee
Thu, Dec 17 · 07:00 UTC · Online
How does the cortex integrate conflicting time-information? A model of temporal averaging
Benjamin De Corte· University of Iowa, USA
Recorded
In daily life, we consistently make decisions in pursuit of some goal. Many decisions are informed by multiple sources of information. Unfortunately, these sources often provide ambiguous information about what course of action to take. Therefore, determining how the brain integrates information to resolve this ambiguity is key to understanding the neural mechanisms of decision-making. In the domain of time, this topic can be studied by training subjects to predict when a future event will occur based on distinct cues (e.g., tone, light, etc.). If multiple cues are presented simultaneously and their cue-to-event intervals differ (e.g., tone-10s + light-30s), subjects will often expect the event to occur at the average of their intervals. This ‘temporal averaging’ effect is presumably how the timing system resolves ambiguous time-information. The neural mechanisms of temporal averaging are currently unclear. Here, we will propose how temporal averaging could emerge in cortical circuits using a simple modification of a ‘drift-diffusion’ model of timing.
How Memory Guides Value-Based Decisions
Daphna Shohamy· Columbia University
Thu, Dec 17 · 01:00 UTC · Online
From robots to humans, the ability to learn from experience turns a rigid response system into a flexible, adaptive one. In this talk, I will discuss emerging findings regarding the neural and cognitive mechanisms by which learning shapes decisions. The lecture will focus on how multiple brain regions interact to support learning, what this means for how memories are built, and the consequences for how decisions are made. Results emerging from this work challenge the traditional view of separate learning systems and advance understanding of how memory biases decisions in both adaptive and maladaptive ways.
Vulnerable periods of brain development in ion channelopathies
Dirk Isbrandt· Deutsches Zentrum fur Neurodegenerative Erkrankunngen
Wed, Dec 16 · 16:00 UTC · Online
Brain and neuronal network development depend on a complex sequence of events, which include neurogenesis, migration, differentiation, synaptogenesis, and synaptic pruning. Perturbations to any of these processes, for example associated with ion channel gene mutations (i.e., channelopathies), can underlie neurodevelopmental disorders such as neonatal and infantile epilepsies, strongly impair psychomotor development and cause persistent deficits in cognition, motor skills, or motor control. The therapeutic options available are very limited, and prophylactic therapies for patients at an increased risk of developing such epilepsies do not exist yet. By using genetic mouse models in which we controlled the activities of Kv7/M or HCN/h-channels during different developmental periods, we obtained offspring with distinct neurological phenotypes that could not simply be reversed by the re-introduction of the affected ion channel in juvenile or adult animals. The results indicate that channelopathy/mutation-specific treatments of neonatal and infantile epilepsies and their comorbidities need to be targeted to specific sensitive periods.
European University for Brain and Technology Virtual Opening
Virtual Opening· European University for Brain and Technology (NeurotechEU)
Wed, Dec 16 · 09:00 UTC · Online
The European University for Brain and Technology, NeurotechEU, is opening its doors on the 16th of December. From health & healthcare to learning & education, Neuroscience has a key role in addressing some of the most pressing challenges that we face in Europe today. Whether the challenge is the translation of fundamental research to advance the state of the art in prevention, diagnosis or treatment of brain disorders or explaining the complex interactions between the brain, individuals and their environments to design novel practices in cities, schools, hospitals, or companies, brain research is already providing solutions for society at large. There has never been a branch of study that is as inter- and multi-disciplinary as Neuroscience. From the humanities, social sciences and law to natural sciences, engineering and mathematics all traditional disciplines in modern universities have an interest in brain and behaviour as a subject matter. Neuroscience has a great promise to become an applied science, to provide brain-centred or brain-inspired solutions that could benefit the society and kindle a new economy in Europe. The European University of Brain and Technology (NeurotechEU) aims to be the backbone of this new vision by bringing together eight leading universities, 250+ partner research institutions, companies, societal stakeholders, cities, and non-governmental organizations to shape education and training for all segments of society and in all regions of Europe. We will educate students across all levels (bachelor’s, master’s, doctoral as well as life-long learners) and train the next generation multidisciplinary scientists, scholars and graduates, provide them direct access to cutting-edge infrastructure for fundamental, translational and applied research to help Europe address this unmet challenge.
Biomedical Engineering
Retrieval spikes: a dendritic mechanism for retrieval-dependent memory consolidation
Erez Geron· NYU
Recorded
Human TREM2 knockout microglia fail to activate towards Alzheimer’s disease pathology
Amanda McQuade· UC Irvine
Recorded
Sleep features for memory consolidation and network building across the lifespan
Gina Poe· University of California, Los Angeles, Integrative Biology & Physiology
Wed, Dec 16 · 06:15 UTC · Online
To communicate effectively, two individuals must take turns to prevent overlap in their signals. How does the nervous system coordinate vocalizations between two individuals? Female and male plain-tailed wrens sing a duet in which they alternate syllable production so rapidly and precisely it sounds as if a single bird is singing. I will talk about experiments that examine the interaction between sensory cues and motor activity, using behavioral manipulations and neurophysiological recordings from pairs of awake, duetting wrens. I will show evidence that auditory cues link the brains of the wrens by modulating motor circuits.
Correlations, chaos, and criticality in neural networks
Moritz Helias· Juelich Research Center
Recorded
The remarkable properties of information-processing of biological and of artificial neuronal networks alike arise from the interaction of large numbers of neurons. A central quest is thus to characterize their collective states. The directed coupling between pairs of neurons and their continuous dissipation of energy, moreover, cause dynamics of neuronal networks outside thermodynamic equilibrium. Tools from non-equilibrium statistical mechanics and field theory are thus instrumental to obtain a quantitative understanding. We here present progress with this recent approach [1]. On the experimental side, we show how correlations between pairs of neurons are informative on the dynamics of cortical networks: they are poised near a transition to chaos [2]. Close to this transition, we find prolongued sequential memory for past signals [3]. In the chaotic regime, networks offer representations of information whose dimensionality expands with time. We show how this mechanism aids classification performance [4]. Together these works illustrate the fruitful interplay between theoretical physics, neuronal networks, and neural information processing.
Targeting stem cells for neurodevelopmental disorders
Xinyu Zhao· University of Wisconsin–Madison
Wed, Dec 16 · 05:00 UTC · Online
Rethinking neuroconstructivism through brain organoids at single cell resolution
Tue, Dec 15 · 17:00 UTC · Online
Contextual effects in the representation of complex sounds: from the inferior colliculus to higher-order cortical fields
Israel Nelken· Edmond and Lily Safra Center for Brain Sciences, Jerusalem, Israel
Mon, Dec 14 · 16:00 UTC · Online
Blurring the boundaries between neuroscience and organismal physiology
Gérard Karsenty· Columbia University
Mon, Dec 14 · 15:00 UTC · Online
Work in my laboratory is based on the assumptions that we do not know yet how all physiological functions are regulated and that mouse genetics by allowing to identify novel inter-organ communications is the most efficient ways to identify novel regulation of physiological functions. We test these two contention through the study of bone which is the organ my lab has studied since its inception. Based on precise cell biological and clinical reasons that will be presented during the seminar we hypothesized that bone should be a regulator of energy metabolism and reproduction and identified a bone-derived hormone termed osteocalcin that is responsible of these regulatory events. The study of this hormone revealed that in addition to its predicted functions it also regulates brain size, hippocampus development, prevents anxiety and depression and favors spatial learning and memory by signaling through a specific receptor we characterized. As will be presented, we elucidated some of the molecular events accounting for the influence of osteocalcin on brain and showed that maternal osteocalcin is the pool of this hormone that affects brain development. Subsequently and looking at all the physiological functions regulated by osteocalcin, i.e., memory, the ability to exercise, glucose metabolism, the regulation of testosterone biosynthesis, we realized that are all need or regulated in the case of danger. In other words it suggested that osteocalcin is an hormone needed to sense and overcome acute danger. Consonant with this hypothesis we next showed this led us to demonstrate that bone via osteocalcin is needed to mount an acute stress response through molecular and cellular mechanisms that will be presented during the seminar. overall, an evolutionary appraisal of bone biology, this body of work and experiments ongoing in the lab concur to suggest 1] the appearance of bone during evolution has changed how physiological functions as diverse as memory, the acute stress response but also exercise and glucose metabolism are regulated and 2] identified bone and osteocalcin as its molecular vector, as an organ needed to sense and response to danger.
Defining new multimodal neuroimaging marker for grey matter characterization
Fabrice Crivello· Institut des Maladies Neurodégénératives - CNRS UMR 5293 - Université de bordeaux
Mon, Dec 14 · 11:00 UTC · Online
The human cortical ribbon varies during the lifespan, from childhood to senescence. To study the effects of genetic and environmental factors on these dynamics, one needs to measure specific phenotypes (cortical volume, surface area, thickness, new neuroimaging phenotypes such as intracortical myelination or multimodal ones based on their combination, or their asymmetries) that characterize the cerebral grey matter accurately
Targeting the synapse in Alzheimer’s Disease
Johanna Jackson· UK Dementia Research Institute at Imperial College London
Recorded
Alzheimer’s Disease is characterised by the accumulation of misfolded proteins, namely amyloid and tau, however it is synapse loss which leads to the cognitive impairments associated with the disease. Many studies have focussed on single time points to determine the effects of pathology on synapses however this does not inform on the plasticity of the synapses, that is how they behave in vivo as the pathology progresses. Here we used in vivo two-photon microscopy to assess the temporal dynamics of axonal boutons and dendritic spines in mouse models of tauopathy[1] (rTg4510) and amyloidopathy[2] (J20). This revealed that pre- and post-synaptic components are differentially affected in both AD models in response to pathology. In the Tg4510 model, differences in the stability and turnover of axonal boutons and dendritic spines immediately prior to neurite degeneration was revealed. Moreover, the dystrophic neurites could be partially rescued by transgene suppression. Understanding the imbalance in the response of pre- and post-synaptic components is crucial for drug discovery studies targeting the synapse in Alzheimer’s Disease. To investigate how sub-types of synapses are affected in human tissue, the Multi-‘omics Atlas Project, a UKDRI initiative to comprehensively map the pathology in human AD, will determine the synaptome changes using imaging and synaptic proteomics in human post mortem AD tissue. The use of multiple brain regions and multiple stages of disease will enable a pseudotemporal profile of pathology and the associated synapse alterations to be determined. These data will be compared to data from preclinical models to determine the functional implications of the human findings, to better inform preclinical drug discovery studies and to develop a therapeutic strategy to target synapses in Alzheimer’s Disease[3].
What about antibiotics for the treatment of the dyskinesia induced by L-DOPA?
Elaine Del-Bel· Professor of Physiology,Department of Morphology, Physiology and Basic Pathology, School of Dentistry, Ribeirão Preto (FORP), University of São Paulo.
Recorded
L-DOPA-induced dyskinesia is a debilitating adverse effect of treating Parkinson’s disease with this drug. New therapeutic approaches that prevent or attenuate this side effect is clearly needed. Wistar adult male rats submitted to 6-hydroxydopamine-induced unilateral medial forebrain bundle lesions were treated with L-DOPA (oral or subcutaneous, 20 mg kg-1) once a day for 14 days. After this period, we tested if doxycycline (40 mg kg-1, intraperitoneal, a subantimicrobial dose) and COL-3 (50 and 100 nmol, intracerebroventricular) could reverse LID. In an additional experiment, doxycycline was also administered repeatedly with L-DOPA to verify if it would prevent LID development. A single injection of doxycycline or COL-3 together with L-DOPA attenuated the dyskinesia. Co-treatment with doxycycline from the first day of L-DOPA suppressed the onset of dyskinesia. The improved motor responses to L-DOPA remained intact in the presence of doxycycline or COL-3, indicating the preservation of L-DOPA-produced benefits. Doxycycline treatment was associated with decreased immunoreactivity of FosB, cyclooxygenase-2, the astroglial protein GFAP and the microglial protein OX-42 which are elevated in the basal ganglia of rats exhibiting dyskinesia. Doxycycline also decreased metalloproteinase-2/-9 activity, metalloproteinase-3 expression and reactive oxygen species production. Metalloproteinase-2/-9 activity and production of reactive oxygen species in the basal ganglia of dyskinetic rats showed a significant correlation with the intensity of dyskinesia. The present study demonstrates the anti-dyskinetic potential of doxycycline and its analog compound COL-3 in hemiparkinsonian rats. Given the long-established and safe clinical use of doxycycline, this study suggests that these drugs might be tested to reduce or to prevent L-DOPA-induced dyskinesia in Parkinson’s patients.
Phospholipid regulation in cognitive impairment and vascular dementia
Gloria Patricia Cardona-Gómez· School of Medicine at University of Antioquia, Medellín, Colombia
Recorded
An imbalance in lipid metabolism in neurodegeneration is still poorly understood. Phospholipids (PLs) have multifactorial participation in vascular dementia as Alzheimer, post-stroke dementia, CADASIL between others. Which include the hyperactivation of phospholipases, mitochondrial stress, peroxisomal dysfunction and irregular fatty acid composition triggering proinflammation in a very early stage of cognitive impairment. The reestablishment of physiological conditions of cholesterol, sphingolipids, phospholipids and others are an interesting therapeutic target to reduce the progression of AD. We propose the positive effect of BACE1 silencing produces a balance of phospholipid profile in desaturase enzymes-depending mode to reduce the inflammation response, and recover the cognitive function in an Alzheimer´s animal and brain stroke models. Pointing out there is a great need for new well-designed research focused in preventing phospholipids imbalance, and their consequent energy metabolism impairment, pro-inflammation and enzymatic over-processing, which would help to prevent unhealthy aging and AD progression.